Please assess the completion status of the following clinical trial:

Trial Title: High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically or cytologically confirmed non-small cell lung cancer~  * Medically inoperable stage I or II disease~ * Stage III disease eligible provided the following are true:~    * No supraclavicular node involvement~   * No peripherally located lower lobe tumor AND contralateral upper mediastinal node involvement~* No distant metastasis~* No malignant pleural or pericardial effusion~PATIENT CHARACTERISTICS:~Age~* Not specified~Performance status~* WHO 0-2~Life expectancy~* Not specified~Hematopoietic~* Not specified~Hepatic~* Not specified~Renal~* Not specified~Cardiovascular~* No prior myocardial infarction~* No prior complete bundle branch block~* No other prior cardiovascular disease resulting in New York Heart Association class III or IV heart disease~* No clinically significant cardiac arrhythmias~* No congestive heart failure~Pulmonary~* FEV_1 at least 1.2 L OR~* DLCO at least 60%~Other~* No other prior or concurrent malignancy except cured basal cell skin cancer or carcinoma in situ of the cervix~* No intractable or uncontrolled infection~* No psychological, familial, social, or geographical condition that would preclude study compliance and follow-up~* Able to tolerate a course of radiotherapy~PRIOR CONCURRENT THERAPY:~Biologic therapy~* Not specified~Chemotherapy~* At least 3 weeks since prior chemotherapy~* No prior anthracyclines~* No concurrent chemotherapy~Endocrine therapy~* Not specified~Radiotherapy~* No prior radiotherapy to the chest area~Surgery~* No prior therapeutic surgery to the chest area~Other~* No other prior therapy to the chest area

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).